AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29194392 — intervention group
Group type: EXPERIMENTAL
Intervention: Menu-plus intervention (marketing campaign, employee trainings, promotional materials)
Number of subjects: 8
Study 29194392 — intervention group
Group type: COMPARATOR
Intervention: Menu-only intervention (new healthy child menu items)
Number of subjects: 8
Study 26176357 — intervention group
Group type: EXPERIMENTAL
Intervention: Video distraction (group V)
Number of subjects: 117
Study 26176357 — intervention group
Group type: COMPARATOR
Intervention: Parental presence (group P)
Number of subjects: 117
Study 26176357 — intervention group
Group type: COMPARATOR
Intervention: Combination of video distraction plus parental presence (group VP)
Number of subjects: 117
Study 23405022 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantar perceptual learning task (hardness discrimination training)
Number of subjects: 86
Study 23405022 — intervention group
Group type: COMPARATOR
Intervention: Control group (same task without hardness discrimination)
Number of subjects: 86
Study 21296780 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan-based regimen (n=257)
Number of subjects: 512
Study 21296780 — intervention group
Group type: COMPARATOR
Intervention: Imidapril-based regimen (n=255)
Number of subjects: 512
Study 19447071 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised nursing wound care record
Number of subjects: 126
Study 15337331 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B-12 treatment
Number of subjects: 140
Study 15337331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 10027509 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan (TRP) depletion
Number of subjects: 13
Study 10027509 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine (LYS) depletion
Number of subjects: 13
Study 10027509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 7743570 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0% isoflurane
Number of subjects: 30
Study 7743570 — intervention group
Group type: COMPARATOR
Intervention: 2.5% isoflurane
Number of subjects: 30
Study 7743570 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 2 micrograms.kg‐1 i.v. with 5.0% isoflurane
Number of subjects: 30
Study 2328112 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ciprofloxacin (3 drops, 250 micrograms/mL in saline solution) locally twice a day (group B)
Number of subjects: 60
Study 2328112 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of topical ciprofloxacin and oral ciprofloxacin (group C)
Number of subjects: 60
Study 2328112 — intervention group
Group type: COMPARATOR
Intervention: Oral ciprofloxacin (250 mg orally twice a day) (group A)
Number of subjects: 60
Study 6102409 — intervention group
Group type: EXPERIMENTAL
Intervention: Floctafenine 1.2 g daily
Number of subjects: 30
Study 6102409 — intervention group
Group type: COMPARATOR
Intervention: Enteric-coated acetylsalicylic acid (ACSA) 2.6 g daily
Number of subjects: 30
Study 6102409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31381078 — intervention group
Group type: EXPERIMENTAL
Intervention: Early limited formula
Number of subjects: 0
Study 28376768 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1200 IU)
Number of subjects: 0
Study 28376768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26866417 — intervention group
Group type: EXPERIMENTAL
Intervention: Total knee replacement surgery
Number of subjects: 422
Study 26866417 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle strength
Number of subjects: 422
Study 26866417 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee pain, activity limitations, number of comorbidities, lack of energy
Number of subjects: 422
Study 26866417 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex, number of comorbidities, depression, fatigue
Number of subjects: 422
Study 23834253 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic extracellular matrix protein as an adjunct to standard care
Number of subjects: 45
Study 22818727 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (n=25) attended program sessions with nutrition information, hands-on cooking instruction, and prepared recipes.
Number of subjects: 50
Study 22818727 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=25) received mailed relevant handouts and recipes.
Number of subjects: 50
Study 19030947 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type-A (BTX-A)
Number of subjects: 0
Study 19030947 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0
Study 17635734 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined anticoagulant and antiplatelet therapy
Number of subjects: 0
Study 17635734 — intervention group
Group type: COMPARATOR
Intervention: Antiplatelet therapy alone
Number of subjects: 0
Study 17635734 — intervention group
Group type: COMPARATOR
Intervention: Anticoagulant therapy
Number of subjects: 0
Study 17635734 — intervention group
Group type: COMPARATOR
Intervention: Aspirin and clopidogrel
Number of subjects: 0
Study 17635734 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 0
Study 16034276 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 45
Study 16034276 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate
Number of subjects: 45
Study 12445486 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) infusion (30 microg/30 min)
Number of subjects: 8
Study 12445486 — intervention group
Group type: COMPARATOR
Intervention: Control group (8 healthy subjects)
Number of subjects: 8
Study 9435411 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rHGH) 0.2 mg/kg.day
Number of subjects: 19
Study 9435411 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 19
Study 9435411 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rHGH)
Number of subjects: 19
Study 8085776 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem LP 300 mg (morning administration)
Number of subjects: 46
Study 8085776 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem LP 300 mg (evening administration)
Number of subjects: 46
Study 8085776 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem LP 300 mg (both morning and evening)
Number of subjects: 46
Study 8085776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 2783183 — intervention group
Group type: EXPERIMENTAL
Intervention: KW-5805 (2.5 to 320 mg)
Number of subjects: 3
Study 2783183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 30511840 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (n = 41, 4 capsules/day, equivalent to 2 g of eicosapentaenoic acid plus docosahexaenoic acid)
Number of subjects: 126
Study 30511840 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil (n = 42, 4 capsules/day, equivalent to 2.5 g of α‐linolenic acid)
Number of subjects: 126
Study 30511840 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (control group, n = 43)
Number of subjects: 126
Study 28751544 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 750
Study 28751544 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency catheter (RFC) ablation
Number of subjects: 750
Study 26447153 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH)D concentration ≥30 ng/mL
Number of subjects: 209
Study 26447153 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH)D concentration ≥30 ng/mL in former and current smokers
Number of subjects: 209
Study 26447153 — intervention group
Group type: EXPERIMENTAL
Intervention: VDR FokI AA genotype
Number of subjects: 209
Study 26447153 — intervention group
Group type: EXPERIMENTAL
Intervention: RXR rs7861779 TT genotype
Number of subjects: 209
Study 23359034 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose iterative reconstruction (LD-IR)
Number of subjects: 40
Study 23359034 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose filtered back-projection (SD-FBP)
Number of subjects: 40
Study 21282528 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilisation and Tactile Stimulation (MTS) for 30, 60, or 120 minutes daily for 14 days
Number of subjects: 76
Study 21282528 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation (control group) with no extra therapy
Number of subjects: 76
Study 19411747 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant and psychological intervention
Number of subjects: 60
Study 19411747 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment alone (Control)
Number of subjects: 60
Study 17575244 — intervention group
Group type: EXPERIMENTAL
Intervention: Powerful individuals
Number of subjects: 0
Study 17575244 — intervention group
Group type: COMPARATOR
Intervention: Powerless individuals
Number of subjects: 0
Study 15762362 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative evaluation of surgical margins (IESM)
Number of subjects: 251
Study 15762362 — intervention group
Group type: COMPARATOR
Intervention: Classical quadrantectomy without IESM (Control)
Number of subjects: 251
Study 15762362 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival (IESM)
Number of subjects: 251
Study 15762362 — intervention group
Group type: EXPERIMENTAL
Intervention: Local recurrence-free survival (IESM)
Number of subjects: 251
Study 15762362 — intervention group
Group type: EXPERIMENTAL
Intervention: Distant metastasis-free survival (IESM)
Number of subjects: 251
Study 11867396 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl with bupivacaine 0.015% and epinephrine
Number of subjects: 100
Study 11867396 — intervention group
Group type: COMPARATOR
Intervention: IV fentanyl
Number of subjects: 100
Study 11867396 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine 0.015% with epinephrine
Number of subjects: 100
Study 9741604 — intervention group
Group type: EXPERIMENTAL
Intervention: Aircast Sport-Stirrup
Number of subjects: 24
Study 9741604 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Ankle
Number of subjects: 24
Study 9741604 — intervention group
Group type: COMPARATOR
Intervention: No brace (control)
Number of subjects: 24
Study 7857354 — intervention group
Group type: EXPERIMENTAL
Intervention: Pidotimod (400 mg oral bottle daily)
Number of subjects: 416
Study 7857354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study 2806595 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate initiated on the 2nd day of the menstrual cycle
Number of subjects: 87
Study 2806595 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate initiated on the 3rd day of the menstrual cycle
Number of subjects: 87
Study 2806595 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate initiated on the 4th day of the menstrual cycle
Number of subjects: 87
Study 2806595 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate initiated on the 5th day of the menstrual cycle
Number of subjects: 87
Study 2806595 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate overall
Number of subjects: 87
Study 2806595 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycles with luteal dysfunction
Number of subjects: 87
Study 1054855 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% chlorhexidine gluconate gel
Number of subjects: 12
Study 1054855 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 12
Study 31529767 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic azithromycin
Number of subjects: 26
Study 31529767 — intervention group
Group type: COMPARATOR
Intervention: No azithromycin
Number of subjects: 26
Study 30808282 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP1 vaccination in Dar es Salaam
Number of subjects: 30156
Study 30808282 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP3 vaccination in Dar es Salaam
Number of subjects: 30156
Study 30808282 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP1 vaccination in Morogoro
Number of subjects: 30156
Study 30808282 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP3 vaccination in Morogoro
Number of subjects: 30156
Study 30808282 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal education in Morogoro
Number of subjects: 30156
Study 30808282 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal education in Morogoro
Number of subjects: 30156
Study 30808282 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal care visit timing in Dar es Salaam
Number of subjects: 30156
Study 30808282 — intervention group
Group type: EXPERIMENTAL
Intervention: Home birth in Morogoro
Number of subjects: 30156
Study 30808282 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger maternal age and poorer households
Number of subjects: 30156
Study 28506305 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy counseling module by pharmacists
Number of subjects: 162
Study 25594768 — intervention group
Group type: EXPERIMENTAL
Intervention: n-CAP dentifrice
Number of subjects: 82
Study 25594768 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser
Number of subjects: 82
Study 25594768 — intervention group
Group type: COMPARATOR
Intervention: strontium chloride dentifrice (SC)
Number of subjects: 82
Study 24006673 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation of Neiguan (PC 6)
Number of subjects: 60
Study 24006673 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 60
Study 21214685 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (PSI) training
Number of subjects: 42
Study 21214685 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 42
Study 18082830 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium dodecyl sulfate polyacrylamide gel electrophoresis with silver staining
Number of subjects: 18
Study 18082830 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 18
Study 17467889 — intervention group
Group type: COMPARATOR
Intervention: BoNTA 300U
Number of subjects: 59
Study 17467889 — intervention group
Group type: COMPARATOR
Intervention: BoNTA 200U
Number of subjects: 59
Study 17467889 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 14754789 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0
Study 14754789 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 0
Study 14754789 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 11587599 — intervention group
Group type: COMPARATOR
Intervention: Assistive listening device
Number of subjects: 60
Study 11587599 — intervention group
Group type: COMPARATOR
Intervention: Conventional hearing aid (nonprogrammable)
Number of subjects: 60
Study 11587599 — intervention group
Group type: COMPARATOR
Intervention: Programmable hearing aid (directional microphone)
Number of subjects: 60
Study 11587599 — intervention group
Group type: COMPARATOR
Intervention: No amplification (control)
Number of subjects: 60
Study 9120506 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health RCTs
Number of subjects: 603
Study 9120506 — intervention group
Group type: COMPARATOR
Intervention: Non-randomized studies
Number of subjects: 603
Study 9120506 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall RCTs
Number of subjects: 603
Study 8506888 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized ambulatory medical record system with health care maintenance reminders
Number of subjects: 49
Study 8506888 — intervention group
Group type: COMPARATOR
Intervention: Conventional paper record with health care maintenance flow sheet
Number of subjects: 49
Study 8506888 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized ambulatory medical record system
Number of subjects: 49
Study 2979690 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg intravenous)
Number of subjects: 8
Study 2979690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 28945118 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVIGATE
Number of subjects: 404
Study 28945118 — intervention group
Group type: COMPARATOR
Intervention: Community Care
Number of subjects: 404
Study 27231000 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min e-learning intervention focused on the fundamentals of the flags approach to clinical judgement-making regarding risk of future pain-related disability
Number of subjects: 0
Study 27231000 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 25329159 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 long‐chain polyunsaturated fatty acids (n‐3 LCPUFA) 4 g daily for 8 weeks
Number of subjects: 0
Study 25329159 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (OO) 4 g daily for 8 weeks
Number of subjects: 0
Study 23768666 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination task
Number of subjects: 37
Study 23768666 — intervention group
Group type: COMPARATOR
Intervention: Distraction control condition
Number of subjects: 37
Study 20042560 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of diabetes of 20 or more years
Number of subjects: 2368
Study 20042560 — intervention group
Group type: EXPERIMENTAL
Intervention: Microalbuminuria
Number of subjects: 2368
Study 20042560 — intervention group
Group type: EXPERIMENTAL
Intervention: Macroalbuminuria
Number of subjects: 2368
Study 20042560 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of diabetes
Number of subjects: 2368
Study 17467944 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast Enhanced Intraoperative Ultrasound (CE-IOUS)
Number of subjects: 39
Study 17467944 — intervention group
Group type: COMPARATOR
Intervention: Combination of preoperative CE-CT and IOUS
Number of subjects: 39
Study 17467944 — intervention group
Group type: EXPERIMENTAL
Intervention: CE-IOUS
Number of subjects: 39
Study 16955301 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 100
Study 16955301 — intervention group
Group type: COMPARATOR
Intervention: Conventional suture ligation technique
Number of subjects: 100
Study 12709699 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic clip placement
Number of subjects: 413
Study 12709699 — intervention group
Group type: COMPARATOR
Intervention: No clip (control)
Number of subjects: 413
Study 11256057 — intervention group
Group type: COMPARATOR
Intervention: Five structured clinical interviews (SCI-PAS, SCI-MOODS, SCI-SHY, SCI-OBS, SCI-ABS) administered along with a diagnostic interview and self-report instruments.
Number of subjects: 0
Study 11256057 — intervention group
Group type: COMPARATOR
Intervention: Panic-agoraphobia spectrum assessment with defined cut-off score.
Number of subjects: 0
Study 11256057 — intervention group
Group type: COMPARATOR
Intervention: Self-report instruments assessing eating disorders.
Number of subjects: 0
Study 9346220 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (175 mg/m2 over 3 hours) with carboplatin (AUC 5)
Number of subjects: 145
Study 9346220 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel (175 mg/m2 over 3 hours) with cisplatin (75 mg/m2)
Number of subjects: 145
Study 8452174 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleroxacin 400 mg orally once daily for 4-21 days
Number of subjects: 285
Study 8452174 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate potassium (AMX/CP) 500 mg/125 mg orally three times daily for 4-21 days
Number of subjects: 285
Study 3544698 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco abstinence condition
Number of subjects: 70
Study 30713173 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear twin-block
Number of subjects: 62
Study 30713173 — intervention group
Group type: COMPARATOR
Intervention: Classic twin-block
Number of subjects: 62
Study 27707723 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot water immersion at 40.5°C for 60 minutes
Number of subjects: 10
Study 27707723 — intervention group
Group type: COMPARATOR
Intervention: Control (seated rest for 60 minutes)
Number of subjects: 10
Study 24767423 — intervention group
Group type: EXPERIMENTAL
Intervention: adapted-NFPP
Number of subjects: 329
Study 24767423 — intervention group
Group type: EXPERIMENTAL
Intervention: IY
Number of subjects: 329
Study 24767423 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 329
Study 22480794 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinzaparin (175 IU/kg)
Number of subjects: 29
Study 22480794 — intervention group
Group type: COMPARATOR
Intervention: Dalteparin (200 IU/kg)
Number of subjects: 29
Study 22480794 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinzaparin
Number of subjects: 29
Study 22480794 — intervention group
Group type: COMPARATOR
Intervention: Dalteparin
Number of subjects: 29
Study 20418272 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 7599
Study 20418272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7599
Study 18361438 — intervention group
Group type: EXPERIMENTAL
Intervention: D-amphetamine (0.5 mg/kg)
Number of subjects: 0
Study 18361438 — intervention group
Group type: COMPARATOR
Intervention: AMPT (3 g/70 kg/day over 44 h)
Number of subjects: 0
Study 16181877 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte filter
Number of subjects: 159
Study 16181877 — intervention group
Group type: COMPARATOR
Intervention: Conventional filter
Number of subjects: 159
Study 11921113 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 199
Study 9810937 — intervention group
Group type: EXPERIMENTAL
Intervention: Dizzy subjects
Number of subjects: 262
Study 9810937 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 262
Study 8589783 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Number of subjects: 21
Study 8589783 — intervention group
Group type: COMPARATOR
Intervention: Nonketogenic diet
Number of subjects: 21
Study 3287703 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (16 mg/kg/day IV for 3 days, then 400 mg t.i.d. for 28 days)
Number of subjects: 297
Study 3287703 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 297
Study 3287703 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297